Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Plos One|October 3, 2013
HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention studyLi-Hua Ping, Cassandra B Jabara, Allen G Rodrigo, et al.
Journal of Virology|April 10, 2020
Deep Sequencing Reveals Compartmentalized HIV-1 in the Semen of Men with and without Sexually Transmitted Infection-Associated UrethritisOlivia D Council, Shuntai Zhou, Chase D McCann, et al.
Molecular Biology and Evolution|February 6, 2019
Constrained Mutational Sampling of Amino Acids in HIV-1 Protease EvolutionJeffrey I Boucher, Troy W Whitfield, Ann Dauphin, et al.
Journal of Virology|September 29, 2004
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1Kimberly Ritola, Christopher D Pilcher, Susan A Fiscus, et al.
The Journal of Infectious Diseases|August 6, 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.
Vaccine|July 12, 2005
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660Robert E Johnston, Philip R Johnson, Mary J Connell, et al.
Journal of Virology|July 31, 2015
R5 Macrophage-Tropic HIV-1 in the Male Genital TractMaria M Bednar, Blake M Hauser, Li-Hua Ping, et al.
The Journal of Infectious Diseases|May 7, 2021
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian CellsShuntai Zhou, Collin S Hill, Sanjay Sarkar, et al.
The Journal of Infectious Diseases|April 29, 2010
A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, RussiaAlexey E Masharsky, Elena N Dukhovlinova, Sergei V Verevochkin, et al.
Journal of Medicinal Chemistry|August 7, 2019
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate EnvelopeLinah N Rusere, Gordon J Lockbaum, Sook-Kyung Lee, et al.
Pageof 18